Abstract: A sample scraping method and a sample scraping device capable of efficiently scraping and collecting a biological tissue section without waste while suppressing contamination is provided. In a sample scraping method for scraping and collecting a biological tissue section held on a slide, the FFPE section held on the slide is heated, and the heated FFPE section is scraped by a blade such that the FFPE section that has been scraped off and remains on the blade is collected in a container.

Abstract: Embodiments provided herein relate to methods and compositions for treating mesothelioma and/or a small cell lung cancer that express midkine.

Abstract: In a dispensing system, a body is arranged outside a specimen processing cabinet, and in a state where a hand and a dispenser are inserted into the specimen processing cabinets, a specimen accommodated in a specimen container held by the hand is dispensed into a dispensing container by the dispenser.

Abstract: Embodiments provided herein relate to methods and compositions for treating mesothelioma and/or a small cell lung cancer that express midkine.

Abstract: A sample scraping method and a sample scraping device capable of efficiently scraping and collecting a biological tissue section without waste while suppressing contamination is provided. In a sample scraping method for scraping and collecting a biological tissue section held on a slide, the FFPE section held on the slide is heated, and the heated FFPE section is scraped by a blade such that the FFPE section that has been scraped off and remains on the blade is collected in a container.

Abstract: Embodiments provided herein relate to methods and compositions for treating mesothelioma and/or a small cell lung cancer that express midkine.

Abstract: Embodiments provided herein relate to methods and compositions for treating mesothelioma and/or a small cell lung cancer that express midkine.

Abstract: Disclosed is a nucleic acid amplification method. The method comprises: performing a first nucleic acid amplification using a target nucleic acid contained in a sample as a template; and performing a second nucleic acid amplification using the amplification product produced in the first nucleic acid amplification step as a template. In the first nucleic acid amplification, a DNA polymerase that selectively amplifies a nucleic acid not comprising a uracil base is used to produce an amplification product that does not comprise a uracil base. In the second nucleic acid amplification, (i) dUTP and/or a primer comprising a uracil base, and (ii) a DNA polymerase capable of amplifying a nucleic acid comprising a uracil base are used to produce an amplification product that comprises a uracil base.

Abstract: Embodiments provided herein relate to methods and compositions for treating mesothelioma and/or a small cell lung cancer that express midkine.

Abstract: Embodiments provided herein relate to methods and compositions for treating mesothelioma and/or a small cell lung cancer that express midkine.

Abstract: Embodiments provided herein relate to methods and compositions for treating cancer. Some embodiments include treating lung cancers and renal cancers.

Abstract: Embodiments provided herein relate to methods and compositions for treating mesothelioma and/or a small cell lung cancer that express midkine.

Abstract: Disclosed is a nucleic acid amplification method. The method comprises: performing a first nucleic acid amplification using a target nucleic acid contained in a sample as a template; and performing a second nucleic acid amplification using the amplification product produced in the first nucleic acid amplification step as a template. In the first nucleic acid amplification, a DNA polymerase that selectively amplifies a nucleic acid not comprising a uracil base is used to produce an amplification product that does not comprise a uracil base. In the second nucleic acid amplification, (i) dUTP and/or a primer comprising a uracil base, and (ii) a DNA polymerase capable of amplifying a nucleic acid comprising a uracil base are used to produce an amplification product that comprises a uracil base.

Abstract: Embodiments provided herein relate to methods and compositions for treating cancer. Some embodiments include treating lung cancers and renal cancers.

Abstract: Embodiments provided herein relate to methods and compositions for treating cancer. Some embodiments include treating lung cancers and renal cancers.

Abstract: Disclosed is a novel method for the selective molecular conversion of raw material carbon nanotubes containing a mixture of metallic carbon nanotubes and semiconductive carbon nanotubes in a manner that is based on the electrical properties or diameter of the carbon nanotubes. The present invention causes a photoreaction of raw material carbon nanotubes containing a mixture of metallic carbon nanotubes and semiconductive carbon nanotubes with a disulfide or a sulfide of the following formula (I) or (II) (wherein R1 and R2 each independently represent a hydrocarbon group that may have a substituent) in an organic solvent that contains the raw material carbon nanotubes and the disulfide of the formula (I) or the sulfide of the formula (II), so as to selectively functionalize the metallic carbon nanotubes, or functionalize the carbon nanotubes diameter selectively.

Abstract: A drive device includes a moving body having a driven portion with an engagement holding portion and an insertion portion, and an element holding portion holding an optical element; a piezoelectric driver having a piezoelectric element and a drive axis that moves the moving body while being inserted into the insertion portion; and a leaf spring being inserted into the insertion portion, being held by the moving body and urging the drive axis to the driven portion in a pressing direction. In a state in which the leaf spring is inserted into the insertion portion, the leaf spring is elastically deformed in the insertion portion by inserting the drive axis which is inserted into the insertion portion, and the drive axis is pressed against the driven portion by the leaf spring, while the leaf spring is engaged with the engagement holding portion and held by the moving body.

Abstract: A process for producing functionalized carbon nanotubes, which can organically modify carbon nanotubes with high efficiency, and in particular, can introduce different organic groups into carbon nanotubes with high efficiency through a series of chemical reactions, is provided. Carbon nanotubes are allowed to react with at least one reagent selected from a silyl-substituted organometallic compound and an organometallic compound to obtain a functionalized carbon nanotube reductant, and this functionalized carbon nanotube reductant is then allowed to react with at least one reagent selected from a silyl halide compound and an organohalogen compound to obtain functionalized carbon nanotubes.

Abstract: Provided are a transparent electroconductive thin film of single-walled carbon nanotubes and its production method capable of further enhancing the electroconductivity and the light transmittance of the film and capable of simplifying the thin film formation process. The method comprises: dispersing single-walled carbon nanotubes of mixed metallic single-walled carbon nanotubes (m-SWNTs) and semiconductor single-walled carbon nanotubes (s-SWNTs) in an amine solution containing an amine having a boiling point of from 20 to 400° C. as a dispersant; centrifuging or filtering the resulting dispersion to concentrate m-SWNTs, thereby giving a dispersion rich in m-SWNTs; and applying the resulting dispersion rich in m-SWNTs onto a substrate to form a thin film thereon.

Abstract: Disclosed is a novel method for the selective molecular conversion of raw material carbon nanotubes containing a mixture of metallic carbon nanotubes and semiconductive carbon nanotubes in a manner that is based on the electrical properties or diameter of the carbon nanotubes. The present invention causes a photoreaction of raw material carbon nanotubes containing a mixture of metallic carbon nanotubes and semiconductive carbon nanotubes with a disulfide or a sulfide of the following formula (I) or (II) (wherein R1 and R2 each independently represent a hydrocarbon group that may have a substituent) in an organic solvent that contains the raw material carbon nanotubes and the disulfide of the formula (I) or the sulfide of the formula (II), so as to selectively functionalize the metallic carbon nanotubes, or functionalize the carbon nanotubes diameter selectively.